Monika Łysakowska

Dr. Monika Łysakowska


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2013 in Molecules
Verified
Journal Article
Open access
PDF file
MSMonika Sienkiewicz
Monika Sienkiewicz
MŁMonika Łysakowska
Monika Łysakowska
MPMarta Pastuszka
Marta Pastuszka
WBWojciech Bienias
Wojciech Bienias
EKEdward Kowalczyk
Edward Kowalczyk
The considerable therapeutical problems of persistent infections caused by multidrug-resistant bacterial strains constitute a continuing need to find effective antimicrobial agents. The aim of this study was to demonstrate the activities of basil (Ocimum basilicum L.) and rosemary (Rosmarinus officinalis L.) essential oils against multidrug- resistant clinical strains of Escherichia coli. A detailed analysis was performed of the resistance of the drug to the strains and their sensitivity to the tested oils. The antibacterial activity of the oils was tested against standard strain Escherichia coli ATCC 25922 as well as 60 other clinical strains of Escherichia coli. The clinical strains were obtained from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from hospital equipment. The inhibition of microbial growth by both essential oils, presented as MIC values, were determined by agar dilution. Susceptibility testing to antibiotics was carried out using disc diffusion. The results showed that both tested essential oils are active against all of the clinical strains from Escherichia coli including extended-spectrum β-lactamase positive bacteria, but basil oil possesses a higher ability to inhibit growth. These studies may hasten the application of essential oils in the treatment and prevention of emergent resistant strains in nosocomial infections.

12 December 2014 in Molecules
Verified
Journal Article
Open access
PDF file
MSMonika Sienkiewicz
Monika Sienkiewicz
AGAnna Głowacka
Anna Głowacka
EKEdward Kowalczyk
Edward Kowalczyk
AWAnna Wiktorowska-Owczarek
Anna Wiktorowska-Owczarek
Marta Jóźwiak-BębenistaMarta Jóźwiak-Bębenista
Marta Jóźwiak-Bębenista
MŁMonika Łysakowska
Monika Łysakowska
Acinetobacter sp. represent an important cause of nosocomial infections. Their resistance to some antibiotics, their ability to survive on inanimate surfaces in the hospital environment and their ability to produce biofilms contributes to their virulence. The aim of the study was to determine the antibacterial properties of cinnamon, lavender and geranium essential oils against bacteria of the genus Acinetobacter isolated from several clinical materials and from the hospital environment. A comprehensive evaluation of the susceptibility of Acinetobacter sp. clinical strains to recommended antibiotics was performed. The constituents of cinnamon, lavender and geranium essential oils were identified by GC-FID-MS analysis, and their Minimal Inhibitory Concentrations (MICs) against tested clinical strains were determined by the micro-dilution broth method. In addition, the effects of essential oils on the viability of human microvascular endothelial cells (HMEC-1) and glioblastoma cell line (T98G) were evaluated. Cinnamon bark oil was the most active against clinical and environmental strains of Acinetobacter baumannii with MIC values ranging from 0.5 to 2.5 µL/mL. The MIC values for geranium oil were between 7.5 and 9.5 µL/mL, and between 10.5 and 13.0 µL/mL for lavender oil. These essential oils can be best employed in the fight against infections caused by bacteria from Acinetobacter genus as components of formulations for hygiene and disinfection of hospital environment.

1 March 2015 in Burns
Verified
Journal Article
Closed access
MŁMonika Łysakowska
Monika Łysakowska
ACAnna Ciebiada-Adamiec
Anna Ciebiada-Adamiec
Leszek KlimekLeszek Klimek
Leszek Klimek
MSMonika Sienkiewicz
Monika Sienkiewicz

ATAnna Tenderenda
Anna Tenderenda
MŁMonika Łysakowska
Monika Łysakowska
RDRobert Dargiewicz
Robert Dargiewicz
Anna  Gawron-Skarbek Anna Gawron-Skarbek
Anna Gawron-Skarbek
In the event of blood culture contamination (BCC), blood culture (BC) needs to be repeated. This may delay appropriate treatment, prolong hospitalization and, consequently, increase its costs. The aim of the study was to assess the frequency of BCC and associated factors in a general hospital in Poland based on reports of BC in samples submitted for laboratory testing in 2019–2020. BCC is recognized when bacteria (especially those belonging to natural human microbiota) are isolated from a single sample and no clinical signs indicated infection. True positive BC is confirmed by the growth of bacteria in more than one set of blood samples with the corresponding clinical signs present. The structure of BC sets, microorganisms, and laboratory costs of BCC were analyzed. Out of 2274 total BC cases, 11.5% were true positive BC and 9.5% were BCC. Of all the BCC identified in the entire hospital, 72% was from Internal Medicine (IM) and Intensive Care Unit (ICU) combined. When single sets for BC were used in IM in 2020, the use increased to 85% compared with 2019 (p < 0.05). The predominant isolates were coagulase-negative staphylococci (84%). The estimated extra laboratory costs of BCC exceeded EUR 268,000. The BCC was a more serious problem than expected, including non-recommended using of single BC sets. Compliance with the BC collection procedure should be increased in order to reduce BCC and thus extra hospital costs.

12 June 2015 in International Endodontic Journal
Verified
Journal Article
Closed access
PDF file
MŁMonika Łysakowska
Monika Łysakowska
ACA. Ciebiada‐Adamiec
A. Ciebiada‐Adamiec
MSM. Sienkiewicz
M. Sienkiewicz
JSJ. Sokołowski
J. Sokołowski
KBK. Banaszek
K. Banaszek

21 December 2015 in Molecules
Verified
Journal Article
Open access
PDF file
MŁMonika Łysakowska
Monika Łysakowska
MSMonika Sienkiewicz
Monika Sienkiewicz
KBKatarzyna Banaszek
Katarzyna Banaszek
JSJerzy Sokołowski
Jerzy Sokołowski
Enterococci are able to survive endodontic procedures and contribute to the failure of endodontic therapy. Thus, it is essential to identify novel ways of eradicating them from infected root canals. One such approach may be the use of antimicrobials such as plant essential oils. Enterococcal strains were isolated from endodontically treated teeth by standard microbiological methods. Susceptibility to antibiotics was evaluated by the disc-diffusion method. The minimal inhibitory concentration (MIC) of geranium essential oil was investigated by microdilution in 96-well microplates in Mueller Hinton Broth II. Biofilm eradication concentrations were checked in dentin tests. Geranium essential oil inhibited enterococcal strains at concentrations ranging from 1.8–4.5 mg/mL. No correlation was shown between resistance to antibiotics and the MICs of the test antimicrobials. The MICs of the test oil were lower than those found to show cytotoxic effects on the HMEC-1 cell line. Geranium essential oil eradicated enterococcal biofilm at concentrations of 150 mg/mL. Geranium essential oil inhibits the growth of endodontic enterococcal species at lower concentrations than those required to reach IC50 against the HMEC-1 cell line, and is effective against bacteria protected in biofilm at higher concentrations. In addition, bacteria do not develop resistance to essential oils. Hence, geranium essential oil represents a possible alternative to other antimicrobials during endodontic procedures.